Tagged with Business

manufacturing The corporate development director and business development manager of UpPharma explain why Market Expansion Services (MES) model represents a unique business opportunity for firms looking to establish themselves in the Mexican pharmaceutical market, why small and medium sized companies are now considering investing in the country and how the vision…

Doing business The councillor at the Swiss Embassy talks about how the two countries have a particularly close relationship when it comes to pharma, the challenge of introducing innovative products to the Mexican market and why Swiss companies are partnering with both medical academies and the authorities. Could you please introduce the…

doing business The president and founder of Knobloch Information Group, the leading supplier of market data to the pharmaceutical industry in Mexico, provides an in-depth overlook about the most important changes that are reshaping the Mexican pharmaceutical market. Knobloch Information Group is the leading supplier of market data to the pharmaceutical industry…

medical devices Philips aims at becoming the leading provider of solutions across the full ‘continuum of care’. The general manager of the healthcare division in Mexico explains how the company has made customer service, education, software and integrated solutions the strategic pillars to find innovative ways to deliver healthcare. What are the…

doing business The longstanding GM of one of the foremost data management services companies for Romanian healthcare analyses some of the key trends sweeping the industry while at he same time outlining the transformational changes taking place with Cegedim’s own service offering. Since we last sat down with you in 2011, what…

MSD One of the so-called ‘new generation’ of pharmaceutical GMs in Romania outlines his first impressions of the local market and details how MSD has managed to shape in-county developments in the infectious disease segment and oncology. You have been working in the industry for 26 years and always with MSD.…

pricing The president and chairman of MC Pharma discusses the position of the pharmacy segment in the current Moroccan healthcare context.  Could you introduce MC Pharma to our international readers, and more especially describe the relationship that exists between MC Pharma and Cooper Pharma? MC Pharma was established in 2002 by…

Doing business The current negotiations for the Trans-Pacific Partnership (TPP) provide Mexico with a not-to-be-missed opportunity to review the country’s intellectual property system. The partner of the life science practice of the most important IP law firm in Mexico discusses the challenges clients from the sector face in the market place and…

doing business The director general of Promopharm explains why Hikma decided to invest in the Moroccan market, why we have to take a long-term perspective when judging the government’s reform agenda and how the main priority will always be responding to patient needs   In 2011 Hikma acquired a 63.9 percent stake…

Roche Ralf Halbach discusses the impact of low health coverage in Morocco on Roche’s strategy, and the fact that the company chose Morocco as the country to locate its northwest Africa management center.   You have been the head of Roche’s northwest Africa management center , as well as the general…

doing business The president of Genpharma talks about the challenge of producing affordable generics in Morocco, his strategy to continue growing in Africa and how his ambition is to become “the Ryanair of African pharma” How has the Moroccan pharmaceutical sector developed over the years, and what is its role within the…

doing business Mayoly Spindler wants to be an international reference in gastroenterology. The general manger of the Mexican affiliate discusses how Mexico is contributing to this goal by always being one step ahead of competitors and leveraging innovation.   Could you please introduce Mayoly Spindler to our readers? Laboratoires Mayoly Spindler is…